NEW YORK (GenomeWeb) – Ginkgo Bioworks and Bayer said today that they have established a new agricultural biotechnology company focused on developing technologies and products for sustainable agriculture. 

The two firms together with venture capital firm Viking Global Investors will provide $100 million in series A funding to the new company. The deal is expected to close this fall.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.